abstract |
Disclosed are: a method for preparing human T cells, which comprises a step of inducing iPS cells from human T cells and a step of differentiating the iPS cells into T cells; a pharmaceutical composition which contains T cells that are prepared by the method; and a method for the treatment of immune cells using the above-described method. |